Publication Name	World Journal of Gastroenterology
Manuscript ID	18279
Country	Taiwan

Received	2015-04-14 14:32
Peer-Review Started	2015-04-16 12:24
To Make the First Decision	2015-05-18 12:59
Return for Revision	2015-05-19 20:57
Revised	2015-06-04 23:55
Second Decision	2015-09-12 21:54
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2015-09-14 11:08
Articles in Press	2015-09-14 11:08
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-09-24 12:19
Publish the Manuscript Online	2015-10-19 09:14

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Active vaccination to prevent de novo hepatitis B virus infection in liver transplantation
Manuscript Source	Invited Manuscript
All Author List	Chih-Che Lin, Chee-Chien Yong and Chao-Long Chen
Funding Agency and Grant Number
Corresponding Author	Chao-Long Chen, MD, Liver Trans­plantation Center, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, 123 Ta-Pei Road, Niao-Sung, Kaohsiung 833, Taiwan. clchen@cgmh.org.tw
Key Words	De novo hepatitis B; Vaccination; Liver transplantation; Core antibody positive donor
Core Tip	De novo hepatitis B virus infection (DNH) can both result in significant morbidity and reduced graft survival after liver transplantation. Utilization of hepatitis B core antibody(+) grafts may increase the risk of DNH. Different approaches to mitigate this risk have been described. There is no widespread consensus regarding the prophylactic measures to reduce the incidence of DNH by active immunization. This review examines the important published studies on DNH, and presents the clinically relevant points in a lucid manner. It also presents an algorithm which is simple to follow, and which has been validated in pediatric patients at our center.
Publish Date	2015-10-19 09:14
Citation	Lin CC, Yong CC, Chen CL. Active vaccination to prevent de novo hepatitis B virus infection in liver transplantation. World J Gastroenterol 2015; 21(39): 11112-11117
URL	http://www.wjgnet.com/1007-9327/full/v21/i39/11112.htm
DOI	http://dx.doi.org/10.3748/wjg.v21.i39.11112

Full Article (PDF)	WJG-21-11112.pdf
Full Article (Word)	WJG-21-11112.doc
Manuscript File	18279-Review.doc
Answering Reviewers	18279-Answering reviewers.pdf
Audio Core Tip	18279-Audio core tip.3gpp
Conflict-of-Interest Disclosure Form	18279-Conflict-of-interest statement.pdf
Copyright License Agreement	18279-Copyright assignment.pdf
Peer-review Report	18279-Peer-review(s).pdf
Scientific Misconduct Check	18279-Scientific misconduct check.pdf
Scientific Editor Work List	18279-Scientific editor work list.pdf